Early clinical experience with the p48MW HPC and p64MW HPC flow diverters in the anterior circulation aneurysm using single anti-platelet treatment

BACKGROUND: The p64MW HPC and p48MW HPC flow diverters have reduced thrombogenicity due to hydrophilic coating. The purpose of this study was to evaluate its safety and efficacy in Mongolian patients under single antiplatelet therapy (SAPT) with prasugrel. MATERIALS AND METHODS: We performed a retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhogal, Pervinder, Petrov, Andrey, Rentsenkhu, Ganbaatar, Nota, Baatarjan, Ganzorig, Erdenebat, Regzengombo, Boldbat, Jagusch, Sara, Henkes, Elina, Henkes, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
New Devices and Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178779/
https://www.ncbi.nlm.nih.gov/pubmed/34233547
http://dx.doi.org/10.1177/15910199211029503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178779/
https://www.ncbi.nlm.nih.gov/pubmed/34233547
http://dx.doi.org/10.1177/15910199211029503

Ejemplares similares